Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 377.80
+2.55 (0.68%)
At close: Feb 13, 2026
Biocon Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 10,133 | 10,225 | 4,627 | 6,484 | 7,405 |
Depreciation & Amortization | 16,403 | 15,341 | 11,131 | 8,142 | 7,107 |
Other Amortization | 467 | 347 | - | - | 44 |
Loss (Gain) From Sale of Assets | -10,497 | 12 | 52 | 23 | -1,524 |
Asset Writedown & Restructuring Costs | 86 | 3,945 | 470 | - | - |
Loss (Gain) From Sale of Investments | 415 | -7,008 | -1,978 | -146 | -113 |
Loss (Gain) on Equity Investments | - | 842 | 1,670 | 2,069 | 794 |
Stock-Based Compensation | 1,370 | 1,006 | 1,376 | 1,257 | 1,060 |
Provision & Write-off of Bad Debts | 290 | -171 | 64 | 248 | 17 |
Other Operating Activities | 12,715 | 11,352 | 6,123 | 1,584 | 1,045 |
Change in Accounts Receivable | 5,482 | -24,174 | 15,905 | -4,736 | -2,788 |
Change in Inventory | -3 | -8,864 | 8,862 | -4,140 | -4,454 |
Change in Accounts Payable | 5,808 | 29,365 | -37,359 | 1,618 | 3,102 |
Change in Other Net Operating Assets | -2,057 | -2,679 | 7,582 | -637 | -98 |
Operating Cash Flow | 40,612 | 29,539 | 18,525 | 11,766 | 11,597 |
Operating Cash Flow Growth | 37.49% | 59.46% | 57.45% | 1.46% | -9.62% |
Capital Expenditures | -21,366 | -16,805 | -15,960 | -16,978 | -15,169 |
Sale of Property, Plant & Equipment | 3 | 233 | 31 | 21 | 96 |
Cash Acquisitions | - | -5,532 | -156,645 | - | - |
Divestitures | 18,252 | - | 34,474 | - | -1,020 |
Sale (Purchase) of Intangibles | -2,067 | -2,511 | -1,303 | -2,270 | -2,294 |
Investment in Securities | 1,665 | 13,124 | -4,648 | 2,314 | -18,512 |
Other Investing Activities | 1,172 | 1,446 | 1,233 | -78 | 652 |
Investing Cash Flow | -2,341 | -10,045 | -142,818 | -16,991 | -36,247 |
Short-Term Debt Issued | 6,846 | 1,248 | 15,041 | 3,461 | - |
Long-Term Debt Issued | 96,582 | 13,718 | 109,399 | 10,701 | 26,569 |
Total Debt Issued | 103,428 | 14,966 | 124,440 | 14,162 | 26,569 |
Short-Term Debt Repaid | - | - | - | - | -345 |
Long-Term Debt Repaid | -99,087 | -28,096 | -395 | -11,070 | -7,401 |
Total Debt Repaid | -99,087 | -28,096 | -395 | -11,070 | -7,746 |
Net Debt Issued (Repaid) | 4,341 | -13,130 | 124,045 | 3,092 | 18,823 |
Issuance of Common Stock | 99 | 307 | 295 | 428 | 407 |
Repurchase of Common Stock | - | - | -647 | -3 | -93 |
Common Dividends Paid | -600 | -2,030 | -599 | - | - |
Other Financing Activities | -22,380 | -8,474 | 7,393 | -1,096 | 6,503 |
Financing Cash Flow | -18,540 | -23,327 | 130,487 | 2,421 | 25,640 |
Foreign Exchange Rate Adjustments | 312 | 29 | 217 | 33 | 71 |
Miscellaneous Cash Flow Adjustments | - | - | - | 338 | -338 |
Net Cash Flow | 20,043 | -3,804 | 6,411 | -2,433 | 723 |
Free Cash Flow | 19,246 | 12,734 | 2,565 | -5,212 | -3,572 |
Free Cash Flow Growth | 51.14% | 396.45% | - | - | - |
Free Cash Flow Margin | 12.61% | 8.63% | 2.30% | -6.37% | -5.00% |
Free Cash Flow Per Share | 16.06 | 10.64 | 2.15 | -4.36 | -2.98 |
Cash Interest Paid | 6,342 | 8,474 | 4,856 | 1,096 | 1,160 |
Cash Income Tax Paid | 4,596 | 2,923 | 2,286 | 2,620 | 1,938 |
Levered Free Cash Flow | -28,162 | 27,613 | 1,402 | -12,380 | -10,577 |
Unlevered Free Cash Flow | -22,614 | 33,703 | 4,021 | -11,958 | -10,216 |
Change in Working Capital | 9,230 | -6,352 | -5,010 | -7,895 | -4,238 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.